© John Wiley & Sons Ltd
Editors-in-Chief: Oliver Keene, Thomas Permutt and Gerd Rosenkranz
Impact Factor: 0.833
ISI Journal Citation Reports © Ranking: 2014: 65/122 (Statistics & Probability); 222/254 (Pharmacology & Pharmacy)
Online ISSN: 1539-1612
Welcome to the new Editor-in-Chief
We are delighted to welcome Tom Permutt as one of three Editors-in-Chief of Pharmaceutical Statistics.
Tom Permutt supervises the statisticians at FDA working on analgesic, pulmonary, and endocrine drugs. He was among the first to apply methods of causal inference, which he had learned by way of econometrics, to questions in biostatistics. He has been interested in the missing data problem since 1975, when he spent a summer at the Census Bureau phoning farmers who hadn’t filled out their census forms.
Tom joins existing editors Oliver Keene and Gerd Rosenkranz in the role.
Recently Published Articles
- Optimal composite scores for longitudinal clinical trials under the linear mixed effects model
M. Colin Ard, Nandini Raghavan and Steven D. Edland
Article first published online: 30 JUL 2015 | DOI: 10.1002/pst.1701
- Bias and precision of measures of survival gain from right-censored data
Karen E. Lamb, Elizabeth J. Williamson, Michael Coory and John B. Carlin
Article first published online: 27 JUL 2015 | DOI: 10.1002/pst.1700